Trexquant Investment’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $78.1M | Buy |
84,926
+54,285
| +177% | +$55M | 0.56% | 15 |
|
|
2025
Q4 | $32.9M | Buy |
30,641
+4,560
| +17% | +$4.36M | 0.29% | 42 |
|
|
2025
Q3 | $19.9M | Buy |
+26,081
| New | +$19.4M | 0.2% | 90 |
|
|
2025
Q2 | – | Sell |
-13,619
| Closed | -$11.2M | – | 1732 |
|
|
2025
Q1 | $11.2M | Buy |
13,619
+9,198
| +208% | +$7.65M | 0.13% | 211 |
|
|
2024
Q4 | $3.41M | Buy |
4,421
+1,871
| +73% | +$1.55M | 0.04% | 661 |
|
|
2024
Q3 | $2.26M | Buy |
+2,550
| New | +$2.29M | 0.03% | 767 |
|
|
2023
Q4 | – | Sell |
-7,213
| Closed | -$3.87M | – | 1639 |
|
|
2023
Q3 | $3.87M | Buy |
+7,213
| New | +$3.72M | 0.1% | 300 |
|
|
2022
Q3 | – | Sell |
-6,574
| Closed | -$2.13M | – | 1646 |
|
|
2022
Q2 | $2.13M | Sell |
6,574
-22,131
| -77% | -$6.64M | 0.1% | 252 |
|
|
2022
Q1 | $8.22M | Sell |
28,705
-8,313
| -22% | -$2.14M | 0.39% | 47 |
|
|
2021
Q4 | $10.2M | Buy |
37,018
+8,244
| +29% | +$2.09M | 0.63% | 16 |
|
|
2021
Q3 | $6.65M | Buy |
+28,774
| New | +$7.1M | 0.53% | 21 |
|
|
2021
Q1 | – | Sell |
-16,668
| Closed | -$2.81M | – | 1309 |
|
|
2020
Q4 | $2.81M | Sell |
16,668
-20,829
| -56% | -$3.11M | 0.3% | 83 |
|
|
2020
Q3 | $5.55M | Buy |
37,497
+10,135
| +37% | +$1.57M | 0.36% | 46 |
|
|
2020
Q2 | $4.49M | Buy |
27,362
+11,141
| +69% | +$1.71M | 0.31% | 67 |
|
|
2020
Q1 | $2.25M | Buy |
+16,221
| New | +$2.23M | 0.16% | 181 |
|
|
2019
Q3 | – | Sell |
-16,957
| Closed | -$1.88M | – | 996 |
|
|
2019
Q2 | $1.88M | Buy |
+16,957
| New | +$2M | 0.17% | 177 |
|
|
2019
Q1 | – | Sell |
-11,842
| Closed | -$1.37M | – | 1157 |
|
|
2018
Q4 | $1.37M | Buy |
11,842
+4,768
| +67% | +$533K | 0.09% | 345 |
|
|
2018
Q3 | $759K | Buy |
+7,074
| New | +$707K | 0.06% | 423 |
|
|
2018
Q1 | – | Sell |
-5,670
| Closed | -$479K | – | 1236 |
|
|
2017
Q4 | $479K | Buy |
+5,670
| New | +$482K | 0.05% | 532 |
|
|
2016
Q2 | – | Sell |
-31,700
| Closed | -$2.28M | – | 987 |
|
|
2016
Q1 | $2.28M | Buy |
+31,700
| New | +$2.4M | 0.27% | 81 |
|
|
2015
Q2 | – | Sell |
-29,600
| Closed | -$2.15M | – | 1115 |
|
|
2015
Q1 | $2.15M | Buy |
29,600
+10,800
| +57% | +$769K | 0.22% | 93 |
|
|
2014
Q4 | $1.3M | Buy |
+18,800
| New | +$1.27M | 0.23% | 79 |
|
Other funds holding LLY
VCM
VPM
Trexquant Investment's LLY Position: Q1 2026 in Review
Trexquant Investment increased its Eli Lilly (LLY) stake by 177% in Q1 2026, buying an estimated $55M and bringing the position to 84,926 shares worth $78.1M. The position accounts for 0.56% of the portfolio, ranked #15.
Trexquant Investment first reported a position in LLY in Q4 2014 and has held it in 22 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Trexquant Investment held 84,926 shares of Eli Lilly worth $78.1M as of Q1 2026.
- Trexquant Investment bought 54,285 Eli Lilly shares in Q1 2026, an estimated $55M.
- Eli Lilly made up 0.56% of Trexquant Investment's portfolio in Q1 2026, its #15 holding.
- Trexquant Investment first reported a position in Eli Lilly in Q4 2014 and has held it in 22 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.